Aman Sidhu

Aman Sidhu

Auto-generated profile, based on publicly available information

Aman Sidhu

Toronto Lung Transplant Program University Health Network Toronto Ontario Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
VSVess Stamenova
Vess Stamenova
KLKyle Liang
Kyle Liang
RYRebecca Yang
Rebecca Yang
KEKatrina Engel
Katrina Engel
FLFlorence van Lieshout
Florence van Lieshout
OBOnil Bhattacharyya
Onil Bhattacharyya
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and leads to frequent hospital admissions and emergency department (ED) visits. COPD exacerbations are an important patient outcome, and reducing their frequency would result in significant cost savings. Remote monitoring and self-monitoring could both help patients manage their symptoms and reduce the frequency of exacerbations, but they have different resource implications and have not been directly compared. Objective: This study aims to compare the effectiveness of implementing a technology-enabled self-monitoring program versus a technology-enabled remote monitoring program in patients with COPD compared with a standard care group. Methods: We conducted a 3-arm randomized controlled trial evaluating the effectiveness of a remote monitoring and a self-monitoring program relative to standard care. Patients with COPD were recruited from outpatient clinics and a pulmonary rehabilitation program. Patients in both interventions used a Bluetooth-enabled device kit to monitor oxygen saturation, blood pressure, temperature, weight, and symptoms, but only patients in the remote monitoring group were monitored by a respiratory therapist. All patients were assessed at baseline and at 3 and 6 months after program initiation. Outcomes included self-management skills, as measured by the Partners in Health (PIH) Scale; patient symptoms measured with the St George’s Respiratory Questionnaire (SGRQ); and the Bristol COPD Knowledge Questionnaire (BCKQ). Patients were also asked to self-report on health system use, and data on health use were collected from the hospital. Results: A total of 122 patients participated in the study: 40 in the standard care, 41 in the self-monitoring, and 41 in the remote monitoring groups. Although all 3 groups improved in PIH scores, BCKQ scores, and SGRQ impact scores, there were no significant differences among any of the groups. No effects were observed on the SGRQ activity or symptom scores or on hospitalizations, ED visits, or clinic visits. Conclusions: Despite regular use of the technology, patients with COPD assigned to remote monitoring or self-monitoring did not have any improvement in patient outcomes such as self-management skills, knowledge, or symptoms, or in health care use compared with each other or with a standard care group. This may be owing to low health care use at baseline, the lack of structured educational components in the intervention groups, and the lack of integration of the action plan with the technology. Trial Registration: ClinicalTrials.gov NCT03741855; https://clinicaltrials.gov/ct2/show/ NCT03741855

17 June 2021 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LWLisa Wickerson
Lisa Wickerson
DHDenise Helm
Denise Helm
CGChaya Gottesman
Chaya Gottesman
DRDmitry Rozenberg
Dmitry Rozenberg
LSLianne G Singer
Lianne G Singer
ASAman Sidhu
Aman Sidhu
Background: The COVID-19 pandemic resulted in a rapid shift from center-based rehabilitation to telerehabilitation for chronic respiratory disease and lung transplantation due to infection control precautions. Clinical experience with this delivery model on a large scale has not been described. Objective: The aim of this study is to describe usage and satisfaction of providers and lung transplant (LTx) candidates and recipients and functional outcomes following the broad implementation of telerehabilitation with remote patient monitoring during the first wave of the COVID-19 pandemic. Methods: This study was a program evaluation of providers, LTx candidates, and early LTx recipients who used a web-based, remote monitoring app for at least four weeks between March 16 and September 1, 2020, to participate in telerehabilitation. Within-subjects analysis was performed for physical activity, Self-efficacy For Exercise (SEE) scale score, aerobic and resistance exercise volumes, 6-minute walk test results, and Short Physical Performance Battery (SPPB) results. Results: In total, 78 LTx candidates and 33 recipients were included (57 [51%] males, mean age 58 [SD 12] years, 58 [52%] with interstitial lung disease, 34 [31%] with chronic obstructive pulmonary disease). A total of 50 (64%) LTx candidates and 17 (51%) LTx recipients entered ≥10 prescribed exercise sessions into the app during the study time frame. In addition, 35/42 (83%) candidates agreed the app helped prepare them for surgery and 18/21 (85%) recipients found the app helpful in their self-recovery. The strongest barrier perceived by physiotherapists delivering the telerehabilitation was patient access to home exercise and monitoring equipment. Between the time of app registration and ≥4 weeks on the waiting list, 26 LTx candidates used a treadmill, with sessions increasing in mean duration (from 16 to 22 minutes, P=.002) but not speed (from 1.7 to 1.75 mph, P=.31). Quadriceps weight (pounds) for leg extension did not change (median 3.5, IQR 2.4-5 versus median 4.3, IQR 3-5; P=.08; n=37). On the Rapid Assessment of Physical Activity questionnaire (RAPA), 57% of LTx candidates scored as active, which improved to 87% (P=.02; n=23). There was a decrease in pretransplant 6-minute walk distance (6MWD) from 346 (SD 84) meters to 307 (SD 85) meters (P=.002; n=45) and no change in the SPPB result (12 [IQR 9.5-12] versus 12 [IQR 10-12]; P=.90; n=42). A total of 9 LTx recipients used a treadmill that increased in speed (from 1.9 to 2.7 mph; P=.003) between hospital discharge and three months posttransplant. Quadriceps weight increased (3 [IQR 0-3] pounds versus 5 [IQR 3.8-6.5] pounds; P<.001; n=15). At three months posttransplant, 76% of LTx recipients scored as active (n=17), with a high total SEE score of 74 (SD 11; n=12). In addition, three months posttransplant, 6MWD was 62% (SD 18%) predicted (n=8). Conclusions: We were able to provide telerehabilitation despite challenges around exercise equipment. This early experience will inform the development of a robust and equitable telerehabilitation model beyond the COVID-19 pandemic.

17 March 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
Javier Tomas Solera RalloJavier Tomas Solera Rallo
Javier Tomas Solera Rallo
BÁBerta G. Árbol
Berta G. Árbol
AMAnkit Mittal
Ankit Mittal
VHVictoria Hall
Victoria Hall
TMTina Marinelli
Tina Marinelli
DKDeepali Kumar
Deepali Kumar
Data regarding COVID-19 outcomes in solid organ transplant recipients(SOTr) across SARS-CoV-2 waves, including the impact of different measures, is lacking. This cohort study, conducted from March 2020-May 2023 in Toronto, Canada, aimed to analyze COVID-19 outcomes in 1,975 SOTr across various SARS-CoV-2 waves and assess the impact of preventive and treatment measures. The primary outcome was severe COVID-19, defined as requiring supplemental oxygen, with secondary outcomes including hospitalization, length of stay, ICU admission, and 30-day and 1-year all-cause mortality. SARS-CoV-2 waves were categorized as Wildtype/Alpha/Delta(318 cases, 16.1%), Omicron-BA.1(268, 26.2%), Omicron-BA.2(268, 13.6%), Omicron-BA.5(561, 28.4%), Omicron-BQ.1.1(188, 9.5%), and Omicron-XBB.1.5(123, 6.2%). Severe COVID-19 rate was highest during the Wildtype/Alpha/Delta wave(44.6%), and lower in Omicron waves(5.7-16.1%). Lung transplantation was associated with severe COVID-19(OR:4.62, 95%CI:2.71-7.89), along with rituximab treatment(OR:4.24, 95%CI:1.04-17.3), long-term corticosteroid use(OR:3.11, 95%CI:1.46-6.62), older age(OR: 1.51, 95%CI:1.30-1.76), chronic lung disease(OR:2.11, 95%CI:1.36-3.30), chronic kidney disease(OR:2.18, 95%CI:1.17-4.07), and diabetes(OR:1.97, 95%CI:1.37-2.83). Early treatment and ≥3 vaccine doses were associated with reduced severity(OR: 0.29, 95%CI:0.19-0.46, and 0.35, 95%CI:0.21-0.60, respectively). Tixagevimab/cilgavimab and bivalent boosters did not show a significant impact. The study concludes that COVID-19 severity decreased across different variants in SOTr. Lung transplantation was associated with worse outcomes and may benefit more from preventive and early therapeutic interventions.

18 June 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
MDMaya Deeb
Maya Deeb
AGAnirudh Gangadhar
Anirudh Gangadhar
MRMadhumitha Rabindranath
Madhumitha Rabindranath
KRKhyathi Rao
Khyathi Rao
MBMichael Brudno
Michael Brudno
MBMamatha Bhat
Mamatha Bhat
Generative artificial intelligence (AI), a subset of machine learning that creates new content based on training data, has witnessed tremendous advances in recent years. Practical applications have been identified in healthcare in general, and there is significant opportunity in transplant medicine for generative AI to simplify tasks in research, medical education as well as clinical practice. Additionally, patients stand to benefit from patient education that is more readily provided by generative AI applications. This review aims to catalyze the development and adoption of generative AI in transplantation by introducing basic AI and generative AI concepts to the transplant clinician, and summarizing its current and potential applications within the field. We provide an overview of applications to the clinician, researcher, educator, and patient. We also highlight the challenges involved in bringing these applications to the bedside, and need for ongoing refinement of generative AI applications to sustainably augment the transplantation field.

9 October 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FLFlorence van Lieshout
Florence van Lieshout
RYRebecca Yang
Rebecca Yang
VSVess Stamenova
Vess Stamenova
PAPayal Agarwal
Payal Agarwal
DPDaniel Cornejo Palma
Daniel Cornejo Palma
JSJames Shaw
James Shaw
Background: Implementing digital health technologies is complex but can be facilitated by considering the features of the tool that is being implemented, the team that will use it, and the routines that will be affected. Objective: The goal of this study was to assess the implementation of a remote-monitoring initiative for patients with chronic obstructive pulmonary disease in Ontario, Canada using the Tool+Team+Routine framework and to refine this approach to conceptualize the adoption of technologies in health care. Methods: This study was a qualitative research project that took place alongside a randomized controlled trial comparing a technology-enabled self-monitoring program with a technology-enabled self- and remote-monitoring program in patients with chronic obstructive pulmonary disease and with standard care. This study included interviews with 5 remote-monitoring patients, 3 self-monitoring patients, 2 caregivers, 5 health care providers, and 3 hospital administrators. The interview questions were structured around the 3 main concepts of the Tool+Team+Routine framework. Results: Findings emphasized that (1) technologies can alter relationships between providers and patients, and that these relationships drove the development of a new service arising from the technology, in our case, and (2) technologies can create additional work that is not visible to management as a result of not being considered within the scope of the service. Conclusions: Literature on the implementation of digital health technologies has still not reconciled the importance of interpersonal relationships to conventional implementation strategies. By acknowledging the centrality of such relationships, implementation teams can better plan for the adaptations required in order to make new technologies work for patients and health care providers. Further work will need to address how specific individuals administering a remote-monitoring program work to build relationships, and how these relationships and other sources of activity might lead to technological scope creep—an unanticipated expanding scope of work activities in relation to the function of the tool.

29 April 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
ASAman Sidhu
Aman Sidhu
CCCecilia Chaparro
Cecilia Chaparro
CCChung‐Wai Chow
Chung‐Wai Chow
MDMeny Davies
Meny Davies
LSLianne G. Singer
Lianne G. Singer